Loading...
Henry Schein, Inc.
HSIC•NASDAQ
HealthcareMedical - Distribution
$70.37
$-0.10(-0.14%)
Henry Schein, Inc. (HSIC) Financial Performance & Statements
Review Henry Schein, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.71%
↑ 2.71%
Operating Income Growth
0.98%
↑ 0.98%
Net Income Growth
-6.25%
↓ 6.25%
Operating Cash Flow Growth
69.60%
↑ 69.60%
Operating Margin
5.22%
↑ 5.22%
Gross Margin
31.11%
↑ 31.11%
Net Profit Margin
3.21%
↑ 3.21%
ROE
11.87%
↑ 11.87%
ROIC
8.74%
↑ 8.74%
Henry Schein, Inc. (HSIC) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Henry Schein, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.19B | $3.17B | $3.14B | $3.17B |
| Cost of Revenue | $2.20B | $2.18B | $2.18B | $2.22B |
| Gross Profit | $993.00M | $993.00M | $955.00M | $951.00M |
| Gross Profit Ratio | $0.31 | $0.31 | $0.30 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $738.00M | $724.00M | $781.00M | $791.00M |
| Operating Expenses | $838.00M | $836.00M | $781.00M | $791.00M |
| Total Costs & Expenses | $3.04B | $3.02B | $2.96B | $3.01B |
| Interest Income | $6.00M | $7.00M | $6.00M | $5.00M |
| Interest Expense | $35.00M | $34.00M | $32.00M | $30.00M |
| Depreciation & Amortization | $76.00M | $74.00M | $74.00M | $73.00M |
| EBITDA | $237.00M | $236.00M | $252.00M | $255.00M |
| EBITDA Ratio | $0.07 | $0.07 | $0.08 | $0.07 |
| Operating Income | $155.00M | $157.00M | $174.00M | $160.00M |
| Operating Income Ratio | $0.05 | $0.05 | $0.06 | $0.05 |
| Other Income/Expenses (Net) | -$29.00M | -$29.00M | -$27.00M | -$23.00M |
| Income Before Tax | $126.00M | $128.00M | $132.00M | $127.00M |
| Income Before Tax Ratio | $0.04 | $0.04 | $0.04 | $0.04 |
| Income Tax Expense | $31.00M | $32.00M | $33.00M | $32.00M |
| Net Income | $94.00M | $99.00M | $104.00M | $93.00M |
| Net Income Ratio | $0.03 | $0.03 | $0.03 | $0.03 |
| EPS | $0.74 | $0.78 | $0.81 | $0.72 |
| Diluted EPS | $0.74 | $0.78 | $0.81 | $0.72 |
| Weighted Avg Shares Outstanding | $126.46M | $126.12M | $127.78M | $128.72M |
| Weighted Avg Shares Outstanding (Diluted) | $127.42M | $127.05M | $128.65M | $129.77M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan